非小细胞肺癌的进展:当前的见解和未来的方向
Pankaj Garg1, Sulabh Singhal2, Prakash Kulkarni3
1Department of Chemistry, GLA University, Mathura 281406, Uttar Pradesh, India.
Journal of clinical medicine
|July 27, 2024
概括
非小细胞肺癌 (NSCLC) 治疗正在推进新的诊断和治疗方法,如向治疗和免疫疗法. 目前正在进行的CAR-T细胞治疗和瘤病毒的研究为改善患者的治疗结果提供了未来的希望.
科学领域:
- 在瘤学瘤学.
- 医学科学 医学科学 医学科学
背景情况:
- 非小细胞肺癌 (NSCLC) 仍然是全球癌症死亡的主要原因.
- 在NSCLC诊断和治疗方面不断改进至关重要.
研究的目的:
- 审查NSCLC管理的最新突破和新兴趋势.
- 突出诊断,向疗法和免疫疗法的进展.
- 讨论在NSCLC治疗中的挑战和未来研究方向.
主要方法:
- 关于NSCLC诊断和治疗近期进展的文献综述.
- 讨论新的治疗策略,包括CAR-T细胞疗法和型病毒.
- 分析当前在治疗可访问性和成本方面的挑战.
主要成果:
- 通过改进的成像和分子生物标志物,增强早期检测和个性化治疗计划.
- 针对高级NSCLC的向疗法和免疫疗法显著改善了患者的治疗结果.
- 识别在获得先进治疗和相关成本方面存在的持续挑战.
结论:
- 最近的进展为NSCLC患者提供了新的希望,特别是那些患有晚期疾病的人.
- 对 CAR-T 细胞疗法和型病毒等新型疗法的持续研究至关重要.
- 解决治疗可访问性和成本方面的挑战对于全球改善NSCLC结果至关重要.
更多相关视频
10:29Semi-automatic PD-L1 Characterization and Enumeration of Circulating Tumor Cells from Non-small Cell Lung Cancer Patients by Immunofluorescence
Published on: August 14, 2019
10.5K
07:42Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients
Published on: February 7, 2021
4.9K
相关概念视频
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
Cancer Therapies
7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K
Cancer Survival Analysis
336
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
336
